
Krystal Biotech Surges 15.8% in a Month: Expert Analysis on Whether to Buy Now or Wait
KRYS Stock: A Surge of Optimism In the past month, the KRYS stock has experienced a significant surge of 15%. This upward trend can be attributed to the strong uptake of the company’s flagship product, Vyjuvek, and encouraging pipeline progress. Let’s delve deeper into the reasons behind this bullish outlook. Vyjuvek’s Success Story Vyjuvek, KRYS’s…